Literature DB >> 21155031

Electrical storms in patients with an implantable cardioverter defibrillator.

Pil Sang Song1, June Soo Kim, Dae-Hee Shin, Jung Wae Park, Ki In Bae, Chang Hee Lee, Dong Chae Jung, Dong Ryeol Ryu, Young Keun On.   

Abstract

PURPOSE: In some patients with an implantable cardioverter defibrillator (ICD), multiple episodes of electrical storm (ES) can occur. We assessed the prevalence, features, and predictors of ES in patients with ICD.
MATERIALS AND METHODS: Eighty-five patients with an ICD were analyzed. ES was defined as the occurrence of two or more ventricular tachyarrhythmias within 24 hours.
RESULTS: Twenty-six patients experienced at least one ES episode, and 16 patients experienced two or more ES episodes. The first ES occurred 209 ± 277 days after ICD implantation. In most ES cases, the index arrhythmia was ventricular tachycardia (65%). There were no obvious etiologic factors at the onset of most ES episodes (57%). More patients with a structurally normal heart (p = 0.043) or ventricular fibrillation (VF) as the index arrhythmia (p = 0.017) were in the ES-free group. Kaplan-Meier estimates and a log-rank test showed that patients with nonischemic dilated cardiomyopathy (DCMP) (log-rank test, p = 0.016) or with left ventricular ejection fraction < 35% (p = 0.032) were more likely to experience ES, and that patients with VF (p = 0.047) were less affected by ES. Cox proportional hazard regression analysis showed that nonischemic DCMP correlated with a greater probability of ES (hazard ratio, 3.71; 95% confidence interval, 1.16-11.85; p = 0.027).
CONCLUSION: ES is a common and recurrent event in patients with an ICD. Nonischemic DCMP is an independent predictor of ES. Patients with VF or with a structurally normal heart are less likely to experience ES.

Entities:  

Mesh:

Year:  2011        PMID: 21155031      PMCID: PMC3017704          DOI: 10.3349/ymj.2011.52.1.26

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  24 in total

1.  Electrical storm in patients with transvenous implantable cardioverter-defibrillators.

Authors:  M A Wood; K A Ellenbogen; L S Liebovitch
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

2.  [Etiologies of electric storm].

Authors:  P Dorian
Journal:  Arch Mal Coeur Vaiss       Date:  1997-04

3.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

4.  Shocks as predictors of survival in patients with implantable cardioverter-defibrillators.

Authors:  A Pacifico; L L Ferlic; F R Cedillo-Salazar; N Nasir; T K Doyle; P D Henry
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

5.  Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm.

Authors:  Atul Verma; Fethi Kilicaslan; Nassir F Marrouche; Stephen Minor; Mohammed Khan; Oussama Wazni; J David Burkhardt; William A Belden; Jennifer E Cummings; Ahmad Abdul-Karim; Walid Saliba; Robert A Schweikert; Patrick J Tchou; David O Martin; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2004-11

6.  Clinical significance of consecutive shocks in patients with left ventricular dysfunction treated with implantable cardioverter defibrillators.

Authors:  Y Endoh; S Ohnishi; H Kasanuki
Journal:  Pacing Clin Electrophysiol       Date:  1999-01       Impact factor: 1.976

7.  Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure.

Authors:  D Böcker; D Bänsch; A Heinecke; M Weber; J Brunn; D Hammel; M Borggrefe; G Breithardt; M Block
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

8.  Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications.

Authors:  S C Credner; T Klingenheben; O Mauss; C Sticherling; S H Hohnloser
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

9.  Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.

Authors:  M M Scheinman; J H Levine; D S Cannom; T Friehling; H A Kopelman; D A Chilson; E V Platia; D J Wilber; P R Kowey
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

10.  Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.

Authors:  P R Kowey; J H Levine; J M Herre; A Pacifico; B D Lindsay; V J Plumb; D L Janosik; H A Kopelman; M M Scheinman
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

View more
  4 in total

1.  Arrhythmic Recurrence and Outcomes in Patients Hospitalized With First Episode of Electrical Storm.

Authors:  Juan Ignacio Damonte; Marco Giuseppe Del Buono; Georgia K Thomas; James Mbualungu; Bennett Clark; Rocco Antonio Montone; Daniel H Berrocal; Tamas S Gal; Le Kang; Juan Lu; Benjamin Van Tassell; Jayanthi Koneru; Thomas C Crawford; Kenneth A Ellenbogen; Antonio Abbate; Jordana Kron
Journal:  Am J Cardiol       Date:  2022-03-30       Impact factor: 3.133

2.  Predictors and clinical impact of inappropriate implantable cardioverter-defibrillator shocks in Korean patients.

Authors:  Jeong Hoon Yang; Kyeongmin Byeon; Hye Ran Yim; Jung Wae Park; Seung-Jung Park; June Huh; June Soo Kim; Young Keun On
Journal:  J Korean Med Sci       Date:  2012-05-26       Impact factor: 2.153

3.  Electroanatomical characteristics of idiopathic left ventricular tachycardia and optimal ablation target during sinus rhythm: significance of preferential conduction through Purkinje fibers.

Authors:  Junbeom Park; Young-Hoon Kim; Chun Hwang; Hui-Nam Pak
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

4.  In-hospital and intermediate term outcome of ventricular tachycardia storm.

Authors:  Vihang Shah; Aniruddha Vyas; Ankeet Dedhia; Neeta Bachani; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2020-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.